Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Serotonin type 3 receptor (5-HT3R) antagonists for negative symptoms and cognitive impairment associated with schizophrenia: a systematic review and meta-analysis
    Published on 2026-06-17
    1 month ago
  • Modulation of early non-rapid eye movement slow wave activity by ketamine in treatment-resistant depression
    Published on 2026-06-16
    1 month ago
  • Early life stress induces sex-specific changes in cognitive and affective behavior associated with disrupted noradrenergic physiology
    Published on 2026-06-15
    1 month ago
  • Phospholipase A2 downregulates inhibitory transmission in the amygdala and impairs fear extinction
    Published on 2026-06-15
    1 month ago
  • IN MEMORIUM – Roger E. Meyer, MD
    Published on 2026-06-12
    2 months ago
  • Nucleus accumbens medial shell D1 and D2 medium spiny neurons signal the valence of conditioned stimuli in a sex-dependent manner
    Published on 2026-06-11
    2 months ago
  • Effort, timing and choice: a refined rodent effort choice task with excellent sensitivity to dopamine modulators
    Published on 2026-06-10
    2 months ago
« Previous 1 … 5 6 7 8 9 … 143 Next »
Journal of Psychopharmacology
  • Effects of benzodiazepines on saccadic eye movements: A systematic review and meta-analysis
    Published on 2026-05-04
    3 months ago
  • 5-HT1A receptor blockade potentiates the subjective effects of DMT
    Published on 2026-05-02
    3 months ago
  • Effects of psychedelic use on authoritarian attitudes revisited
    Published on 2026-05-02
    3 months ago
  • Preliminary evidence that serum interleukin-6 is a candidate biomarker of response to esketamine in treatment-resistant depression
    Published on 2026-04-25
    3 months ago
  • The effects of the PDE4 inhibitor roflumilast on cognitive performance after a cerebrovascular accident: a double-blind randomized placebo-controlled trial with an open label extension (ROSTMEMA)
    Published on 2026-04-25
    3 months ago
  • Substance use predictors of arrest and self-reported criminal behavior in the United States: The role of psychedelics and rarely used drugs
    Published on 2026-04-16
    3 months ago
  • Mismatch negativity in patients with bipolar affective disorder: a systematic review and meta-analysis
    Published on 2026-04-16
    3 months ago
« Previous 1 … 5 6 7 8 9 … 150 Next »
European Neuropsychopharmacology
  • Perinatal bipolar disorder as a critical risk window: rationale for hospitalization at home on this population
    Published on 2026-04-17
    3 months ago
  • Pathway-selective signaling of serotonergic psychedelics at 5-HT receptors: Implications for psychoactivity, safety, and therapeutic potential
    Published on 2026-04-11
    4 months ago
  • Shared and distinct effects of mood stabilizers on epigenetic machinery gene expression: an exploratory study in HeLa cells
    Published on 2026-04-09
    4 months ago
  • Response to “Gene-environment interactions and white matter integrity in mood disorders: Further directions”
    Published on 2026-04-09
    4 months ago
  • Dissecting the pleiotropic genetic architecture of suicide attempt, suicidal ideation, and thirteen correlated traits
    Published on 2026-04-07
    4 months ago
  • Structural brain findings associated with clinical profiles but not diagnosis in unmedicated adults with obsessive-compulsive disorder: the Global OCD study
    Published on 2026-04-03
    4 months ago
  • Sexual dysfunction in bipolar disorder: A systematic review
    Published on 2026-04-01
    4 months ago
« Previous 1 … 5 6 7 8 9 … 168 Next »

   Pharma Pub